Susquehanna International Group, LLP Adverum Biotechnologies, Inc. Call Options Transaction History

Susquehanna International Group, LLP

$560 Billion
Q3 2024

Call Options

24 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2023 Nov 14, 2023	SELL	$1.5 - $2.33 $2,400 - $3,728	-1,600 Reduced 2.84%	54,700 $82,000
Q2 2023 Aug 11, 2023	BUY	$0.68 - $1.59 $612 - $1,431	900 Added 1.62%	56,300 $89,000
Q1 2023 May 16, 2023	SELL	$0.62 - $0.85 $168,206 - $230,605	-271,300 Reduced 83.04%	55,400 $39,000
Q4 2022 Feb 14, 2023	BUY	$0.54 - $10.3 $14,634 - $279,130	27,100 Added 9.05%	326,700 $189,000
Q3 2022 Nov 14, 2022	SELL	$0.96 - $9.68 $17,376 - $175,208	-18,100 Reduced 5.7%	299,600 $285,000
Q2 2022 Aug 15, 2022	SELL	$0.81 - $1.34 $103,680 - $171,520	-128,000 Reduced 28.72%	317,700 $381,000
Q1 2022 May 16, 2022	SELL	$1.23 - $1.95 $501,225 - $794,625	-407,500 Reduced 47.76%	445,700 $584,000
Q4 2021 Feb 14, 2022	BUY	$1.74 - $2.4 $176,958 - $244,080	101,700 Added 13.53%	853,200 $1.5 Million
Q3 2021 Nov 15, 2021	BUY	$2.08 - $3.6 $1.09 Million - $1.89 Million	526,100 Added 233.41%	751,500 $1.63 Million
Q2 2021 Aug 11, 2021	BUY	$3.36 - $10.56 $456,288 - $1.43 Million	135,800 Added 151.56%	225,400 $789,000
Q1 2021 May 17, 2021	SELL	$9.26 - $14.36 $1.35 Million - $2.09 Million	-145,700 Reduced 61.92%	89,600 $883,000
Q4 2020 Feb 16, 2021	BUY	$9.84 - $14.26 $879,696 - $1.27 Million	89,400 Added 61.27%	235,300 $2.55 Million
Q3 2020 Nov 16, 2020	SELL	$10.3 - $21.64 $82,400 - $173,120	-8,000 Reduced 5.2%	145,900 $1.5 Million
Q2 2020 Aug 14, 2020	BUY	$8.53 - $25.64 $979,243 - $2.94 Million	114,800 Added 293.61%	153,900 $3.21 Million
Q1 2020 May 15, 2020	SELL	$7.98 - $16.32 $2.89 Million - $5.9 Million	-361,600 Reduced 90.24%	39,100 $382,000
Q4 2019 Feb 14, 2020	SELL	$5.12 - $12.22 $1.03 Million - $2.46 Million	-201,300 Reduced 33.44%	400,700 $4.62 Million
Q3 2019 Nov 14, 2019	BUY	$5.24 - $15.89 $2.68 Million - $8.12 Million	511,300 Added 563.73%	602,000 $3.28 Million
Q2 2019 Aug 14, 2019	BUY	$5.1 - $11.89 $462,569 - $1.08 Million	90,700 New	90,700 $1.08 Million
Q1 2019 May 15, 2019	SELL	$3.03 - $6.02 $52,116 - $103,543	-17,200 Closed	0 $0
Q4 2018 Feb 14, 2019	SELL	$2.87 - $5.92 $88,396 - $182,336	-30,800 Reduced 64.17%	17,200 $54,000
Q3 2018 Nov 14, 2018	SELL	$4.5 - $7.6 $56,700 - $95,760	-12,600 Reduced 20.79%	48,000 $290,000
Q2 2018 Aug 14, 2018	BUY	$5.3 - $6.9 $135,150 - $175,950	25,500 Added 72.65%	60,600 $321,000
Q1 2018 May 15, 2018	BUY	$3.65 - $7.95 $47,450 - $103,350	13,000 Added 58.82%	35,100 $204,000
Q4 2017 Feb 14, 2018	BUY	$2.85 - $3.95 $62,985 - $87,295	22,100	22,100 $77,000

Others Institutions Holding ADVM

# of Institutions

Shares Held

524K

Call Options Held

Put Options Held

Versant Venture Management, LLC San Francisco, CA

507K
Shares

$2.4 Million
9.32% of portfolio
Pinz Capital Management, LP New York, NY

15.7K
Shares

$74,418
0.03% of portfolio
American Portfolios Advisors Holbrook, NY

1.15K
Shares

$5,451
0.0% of portfolio

View Full List

About Adverum Biotechnologies, Inc.

Ticker ADVM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 99,333,600
Market Cap $471M
Description
Adverum Biotechnologies, Inc., a clinical-stage gene therapy company, develops gene therapy product candidates to treat ocular and rare diseases. Its lead product candidate is ADVM-022, a single intravitreal injection gene therapy candidate used for the treatment of patients with chronic retinal, including wet age-related macular degeneration an...

More about ADVM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.

Account